Repeat balloon valvuloplasty for dogs with recurrent or persistent pulmonary stenosis

Winter, Randolph L.; Rhinehart, Jaylyn; Estrada, Amara H.; Maisenbacher, Herbert W.; Claretti, M.; Bussadori, Claudio; Nguyenba, Thaibinh P.; Scansen, Brian A.; Bonagura, John D.; Schober, Karsten E.

doi:10.1016/j.jvc.2020.12.006

Cited by 6 publications

(2 citation statements)

References 28 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…[5][6][7][8][9][10][11] However, some dogs experience restenosis, RV dysfunction, arrhythmias, or return of clinical signs or heart failure. 10,[12][13][14][15][16] Because it is unclear which dogs will deteriorate over time, there is no consensus on long-term monitoring.…”

Section: Introductionmentioning

confidence: 99%

“…Valvular PS can be treated by balloon valvuloplasty with or without stent implantation, and these procedures generally are considered safe and effective in dogs and humans 5‐11 . However, some dogs experience restenosis, RV dysfunction, arrhythmias, or return of clinical signs or heart failure 10,12‐16 . Because it is unclear which dogs will deteriorate over time, there is no consensus on long‐term monitoring.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Evaluation of right ventricular diastolic function, systolic function, and circulating galectin‐3 concentrations in dogs with pulmonary stenosis

Winter,

Maneval,

Ferrel

et al. 2023

Veterinary Internal Medicne

View full text Add to dashboard Cite

BackgroundCardiovascular diseases with increased right ventricular (RV) afterload induce RV diastolic and systolic dysfunction, and myocardial fibrosis in humans. Studies in dogs with pulmonary stenosis (PS) evaluating RV diastolic function and markers of myocardial fibrosis are lacking.Hypothesis/ObjectivesDogs with PS have echocardiographic evidence of RV diastolic and systolic dysfunction and increased serum concentrations of galectin‐3 (Gal‐3), a surrogate biomarker for myocardial fibrosis.AnimalsForty client‐owned dogs (10 controls, 30 with PS).MethodsProspective study. All dogs had systemic blood pressure measurement, serum biochemical analysis, echocardiography, and measurement of serum Gal‐3 concentration performed.ResultsVariables of RV diastolic function were obtained in 39/40 dogs. Trans‐tricuspid flow velocity in early diastole to trans‐tricuspid flow velocity in late diastole ratios (RV E/A) were lower (P < .001) in dogs with PS (median, 0.94; range, 0.62‐2.04) compared to controls (1.78; 1.17‐2.35). Trans‐tricuspid flow velocity in early diastole to tricuspid annular myocardial velocity in early diastole ratios (RV E/e′) were higher (P < .001) in dogs with PS (11.55; 4.69‐28) compared to control (6.21; 5.16‐7.21). Variables of RV systolic function were lower in dogs with PS (P = <.001). Serum Gal‐3 concentration was higher (P = .002) in dogs with PS (285.1 pg/mL; 94.71‐406.97) compared to control dogs (162.83 pg/mL; 52.3‐232.82).Conclusions and Clinical ImportanceDogs with PS have RV diastolic and systolic dysfunction, and increased Gal‐3 concentrations. These findings suggest the presence of RV myocardial fibrosis in dogs with PS, which could impact clinical management.

show abstract